Skip to Content

EF 4 (Balversa 4 mg)

Generic Name: erdafitinib

Pill with imprint EF 4 is Orange, Round and has been identified as Balversa 4 mg. It is supplied by Janssen Pharmaceuticals, Inc..

Balversa is used in the treatment of urothelial carcinoma; bladder cancer and belongs to the drug class multikinase inhibitors. Balversa 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EF 4

Balversa

Generic Name
erdafitinib
Imprint
EF 4
Strength
4 mg
Color
Orange
Shape
Round
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Janssen Pharmaceuticals, Inc.
National Drug Code (NDC)
59676-0040

Get help with Imprint Code FAQs.

Related Images for "EF 4"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.